Journal News

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder

Meric Ozturk
Sept. 16, 2025

Zellweger spectrum disorder, or ZSD, is a rare genetic disorder that disrupts essential cellular processes in infancy and worsens over time, often leading to blindness and life-threatening complications. Individuals with mild ZSD typically live 30–40 years, though treatment is limited to symptom management. This disorder disrupts essential cellular processes by impairing peroxisomes — small organelles responsible for breaking down toxic substances and producing lipids, which are vital for brain and organ development.

Courtesy of Samy Omri
Confocal microscopy images of retinal pigment epithelium of healthy mice and mice engineered to have Zellweger spectrum disorder–like disease. Images are stained for a microglia/macrophage marker (green) and F-actin (red).

In a recent Journal of Lipid Research study, Samy Omri, a research associate in Nancy Braverman’s lab at McGill University Health Centre, and colleagues focused on mutations in the peroxisomal biogenesis factor 1, or PEX1, gene, the most common cause of ZSD. These mutations disrupt lipid biosynthesis and peroxisome assembly, leading to progressive retinal degeneration — a major cause of childhood blindness in affected individuals.

“Currently, there is no curative treatment, so supportive management aims to alleviate symptoms and improve patients' quality of life,” Omri said. “This includes dietary modifications to address metabolic imbalances, supplementation with essential fatty acids to support neurological function.”

To model ZSD-related retinal degeneration, the researchers used mice with the Pex1-G844D mutation, which mirrors the common human variant.

“The team has been deeply engaged in studying and treating peroxisomal disorders, and this project, investigating the influence of lipid metabolism on retinal health, naturally evolved from that work,” Omri said. “My expertise in retinal physiopathology, along with my interest in early molecular changes preceding inflammation and tissue degeneration, aligns well with the lab's research focus.”

The team focused on retinal pigment epithelium, or RPE, analyzing morphological, inflammatory and lipid changes in a mouse model at one, three and six months of age. They found that RPE degeneration could be detected by three months and worsened with age.

Using mass spectrometry imaging, generated by Pierre Chaurand’s lab, the group identified 47 lipids in RPE that were altered appeared before any visible structural degeneration in the retina. This approach allowed them to visualize the spatial lipid distribution in the retina, providing insight into early disease mechanisms.

“While previous work has largely focused on systemic disease characterization and functional recovery, our research shifts the focus to find new biomarkers for retinal degeneration and a deeper mechanistic understanding of ZSD pathology,” Omri said.

Next, the team plans to validate the clinical relevance of these lipid signatures, a step toward developing future diagnostic tools or therapeutic targets.

They also discovered progressive subretinal macrophage accumulation in ZSD mice, revealing a previously unrecognized inflammatory pathway potentially driving retinal degeneration. Future studies will investigate these inflammatory signal pathways to identify anti-inflammatory therapies that could slow or prevent retinal degeneration.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Meric Ozturk

Meric Ozturk is a Ph.D. student in biochemistry at Iowa State University and an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

ApoA1 reduce atherosclerotic plaques via cell death pathway
Journal News

ApoA1 reduce atherosclerotic plaques via cell death pathway

Oct. 1, 2025

Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
Journal News

Omega-3 lowers inflammation, blood pressure in obese adults

Oct. 1, 2025

A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.

AI unlocks the hidden grammar of gene regulation
Feature

AI unlocks the hidden grammar of gene regulation

Sept. 30, 2025

Using fruit flies and artificial intelligence, Julia Zeitlinger’s lab is decoding genome patterns — revealing how transcription factors and nucleosomes control gene expression, pushing biology toward faster, more precise discoveries.

Zebrafish model links low omega-3s to eye abnormalities
Journal News

Zebrafish model links low omega-3s to eye abnormalities

Sept. 24, 2025

Researchers at the University of Colorado Anschutz developed a zebrafish model to show that low maternal docosahexaenoic acid can disrupt embryo eye development and immune gene expression, offering a tool to study nutrition in neurodevelopment.

Top reviewers at ASBMB journals
Observance

Top reviewers at ASBMB journals

Sept. 19, 2025

Editors recognize the heavy-lifters and rising stars during Peer Review Week.

Teaching AI to listen
Essay

Teaching AI to listen

Sept. 18, 2025

A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.